Caplin Point Lab Share Price

₹ 2,029.10

-₹55.50 (-2.66%)
1D
Last updated 20 Nov, 2026, 15:59 IST
NSE: CAPLIPOINT
|
Pharmaceuticals

Caplin Point Lab Share Price Today

As of 22 Nov 2026, Caplin Point Lab share price is ₹2,029.10. The stock opened at ₹2,089.20, compared to its previous close of ₹2,084.60. During today's trading session, Caplin Point Lab share price moved in the range of ₹2,020.00 to ₹2,126.00, with an average price of ₹2,073.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,500.30 and a high of ₹2,990.00. On the performance front, Caplin Point Lab share price has increased by 0.62% over the last six months and is up 5.65% on a year-on-year basis.

Share price over the last 1 day fell from 2107.60 to 2025.00, ranging between 2020.60 and 2120.00.

₹2,020.00
2.66% down today
₹2,126.00
1D LOW
1D HIGH

Caplin Point Lab Stock Insights

Latest Earning
Op Profit TrendUp by 3.38% QoQ
Latest Earning
Net Profit TrendUp by 1.82% QoQ
Latest Earning
Revenue TrendUp by 2.98% QoQ
Stock Performance
OutperformingBeat Nifty by 6.34 % in last 1 year
Shareholding Pattern
DIIDII decreased stake by 82.87%
Shareholding Pattern
FIIFII decreased stake by 0.60%
Technical Indicators
Bollinger Band breakdownPrice touched below the lower Bollinger Band on 1 Day interval.
Caplin Point Lab stock performance
Open₹2,089.20
High₹2,126.00
Low₹2,020.00
Prev. close₹2,084.60
Caplin Point Lab trading activity
Volume1,65,087
Average traded price₹2,050.71
Last traded time03:59:14 20 Nov
Last traded quantity5

Circuit
L
H
₹1,623.30
₹2,434.90
52-week
L
H
₹1,500.30
₹2,990.00
Mkt Cap Cr
15,421.25

P/E
22.03

P/B
3.95

ROA
16.0%
ROE
17.66%

ROCE
22.21%

Quick Ratio
5.59

EV/EBITDA
15.48

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Caplin Point Lab has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Caplin Point Lab appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Caplin Point Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.87
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.06
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.73
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.64
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.53
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Caplin Point Lab Company Background

ISIN
INE475E01026
Sector Market Cap
₹ 15,421.25 Cr

Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.

Caplin Point Lab Financial Highlights

  • Revenue: Caplin Point Lab reported revenue of ₹2,302.74 crore in FY26 vs ₹2,033.90 crore in FY25. It showed an increase of 13.22% on a yearly basis.
  • Operating Profit: Caplin Point Lab reported an operating profit of ₹802.79 crore in FY26 vs ₹676.78 crore in FY25. It showed an increase of 18.62% on a year-on-year basis.
  • Net Profit: Caplin Point Lab reported a net profit of ₹649.73 crore in FY26 vs ₹541.09 crore in FY25. It showed an increase of 20.08% on a yearly basis.

Caplin Point Lab Quarterly Result Highlights

  • Caplin Point Lab reported revenue of ₹663.13 crore in Sep 2026, compared with ₹643.91 crore in Jun 2026, representing an increase of 2.98% on a quarter-on-quarter (QoQ) basis.
  • Caplin Point Lab reported an operating profit of ₹232.83 crore in Sep 2026, compared with ₹225.22 crore in Jun 2026, representing an increase of 3.38% on a quarter-on-quarter (QoQ) basis.
  • Caplin Point Lab reported a profit of ₹182.35 crore in Sep 2026, compared with ₹179.09 crore in Jun 2026, reflecting an increase of 1.82% on a QoQ basis.
  • The earnings per share (EPS) of Caplin Point Lab stood at ₹84.36 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
70.57%
FII
5.72%
Other DII
0.08%
Retail and other
21.99%
Mutual funds
1.64%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20256.59%
Mar 20266.15%
Jun 20265.75%
Sep 20265.72%

Caplin Point Lab Investment Returns

1 day
-2.66%

1 week
-15.05%

1 month
-10.17%

1 year
+5.65%

3 years
+59.82%

5 years
+140.71%

Caplin Point Lab Share Price History

Caplin Point Lab share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹2,089.20 / ₹2,029.10
-2.66%
19 Nov 26
₹2,060.00 / ₹2,084.60
-0.03%
18 Nov 26
₹2,231.00 / ₹2,085.30
-7.20%
17 Nov 26
₹2,328.00 / ₹2,247.10
-4.25%
Show more

Caplin Point Lab Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,187.19₹1,937.47₹1,694.10₹1,466.73
Other Income₹115.54₹96.43₹66.94₹55.98
Total Revenue₹2,302.73₹2,033.90₹1,761.04₹1,522.71
Total Expenses₹1,499.98₹1,357.11₹1,196.88₹1,071.44
Profit Before Tax₹802.79₹676.78₹564.43₹451.35
Tax₹153.06₹135.69₹103.01₹74.36
Profit After Tax₹649.73₹541.09₹461.42₹376.99
EPS - Basic₹84.36₹70.57₹60.19₹49.62
EPS - Diluted₹84.11₹70.25₹59.90₹49.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹802.79₹676.78₹564.43₹451.35
Income before WC changes₹776.71₹682.29₹566.83₹463.12
Change in Assets-₹319.42-₹117.48-₹228.22-₹178.01
Change in Liabilities₹210.45-₹4.80₹88.78₹74.26
Change in WC-₹108.97-₹122.28-₹139.44-₹103.75
Cash flow from Operations₹523.24₹432.37₹318.39₹271.37
Cash flow from Investing-₹582.30-₹334.73-₹320.04-₹217.58
Cash flow from Financing-₹46.46-₹38.32-₹38.07-₹28.17
Total Cash Flow-₹105.52₹59.32-₹39.72₹25.62
Cash (Start of the year)₹199.45₹138.70₹177.56₹150.76
Cash (End of the year)₹94.18₹199.45₹138.70₹177.56

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,459.82₹1,073.90₹805.20₹639.21
Current Assets₹2,585.66₹2,133.95₹1,892.92₹1,552.19
Total Assets₹4,045.48₹3,207.85₹2,698.12₹2,191.40
Current Liabilities₹385.96₹305.99₹330.85₹268.00
Net Current Asset₹2,199.70₹1,827.96₹1,562.07₹1,284.19
Non-Current Liabilities₹28.72₹15.47₹20.44₹16.13
Equity Capital₹3,630.80₹2,886.39₹2,346.83₹1,907.27
Total Equity & Liabilities₹4,045.48₹3,207.85₹2,698.12₹2,191.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹738.33₹752.41₹625.09₹528.61
Other Income₹195.37₹134.59₹105.84₹99.00
Total Revenue₹933.70₹887.00₹730.93₹627.61
Total Expenses₹426.18₹445.33₹365.19₹334.46
Profit Before Tax₹507.52₹441.67₹365.74₹293.15
Tax₹110.94₹102.18₹82.03₹58.89
Profit After Tax₹396.58₹339.49₹283.71₹234.26
EPS - Basic₹52.17₹44.67₹37.36₹30.89
EPS - Diluted₹52.02₹44.47₹37.18₹30.62

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹507.52₹441.67₹365.74₹293.15
Income before WC changes₹363.71₹357.20₹297.17₹233.58
Change in Assets-₹99.88-₹36.74-₹74.52-₹54.85
Change in Liabilities₹49.06-₹20.75-₹24.55₹43.41
Change in WC-₹50.82-₹57.49-₹99.07-₹11.44
Cash flow from Operations₹203.48₹195.87₹111.01₹157.10
Cash flow from Investing-₹213.47-₹140.20-₹118.94-₹86.67
Cash flow from Financing-₹45.81-₹38.10-₹34.26-₹30.42
Total Cash Flow-₹55.80₹17.57-₹42.19₹40.01
Cash (Start of the year)₹99.64₹80.64₹122.02₹81.01
Cash (End of the year)₹44.09₹99.64₹80.64₹122.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,235.86₹988.79₹819.21₹641.48
Current Assets₹975.88₹825.69₹703.10₹661.70
Total Assets₹2,211.74₹1,814.48₹1,522.31₹1,303.18
Current Liabilities₹144.17₹99.85₹118.87₹146.85
Net Current Asset₹831.71₹725.84₹584.23₹514.85
Non-Current Liabilities₹17.07₹13.70₹13.29₹16.42
Equity Capital₹2,050.50₹1,700.93₹1,390.15₹1,139.91
Total Equity & Liabilities₹2,211.74₹1,814.48₹1,522.31₹1,303.18
* All values are in INR Crore
Caplin Point Lab market depth
Bid quantityBid priceAsk priceAsk quantity
002029.111
0000
0000
0000
0000
Total bid quantity0
Total ask quantity11
Caplin Point Lab technical summary
Bearish indicators3
Neutral indicators1
Bullish indicators4
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
26.74
Bearish

ATR (14)
100.19
Neutral

STOCH(9,6)
2.74
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
30.54
Bearish

UO(9)
28.42
Bullish

ROC(12)
-16.02
Bearish

WillR(14)
-97.26
Bullish
Period
Simple value
Exponential vaue

5D
2158.58
2144.07

10D
2304.79
2233.1

20D
2332.98
2307.74

50D
2480.5
2410.38

100D
2533.55
2406.37
Volume trend — traded volume by day
20 Nov1L
19 Nov2L
18 Nov7L
17 Nov2L
16 Nov0L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Caplin Point Lab
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Caplin Point Lab

Fund name
AUM
UTI Healthcare Fund
2.23%

UTI Small Cap Fund
1.41%

UTI Multi Cap Fund
1.41%

Caplin Point Lab Returns Calculator

Ex-date: 18 Sep 2026

Ex-date: 29 May 2026

Caplin Point Lab Latest News

1 month ago
Max Financial Services, Vardhman Textiles, Caplin Point shares spurt amid spike in volumes
2 months ago
Vardhman Textiles, Graphite India, Engineers India shares surge amid spike in volumes; check full list
3 months ago
Stocks to watch, August 24: Natco Pharma, M&M, RIL, Senco Gold, Caplin Point, real estate stocks, Grasim
Showing news item 1 of 3

Caplin Point Lab Share Price FAQs












Please be aware that Caplin Point Lab stock prices are subject to continuous fluctuations due to various factors.